Loading patent…
AssigneeSnu R&Db Foundation
InventorsSuk Woo Choi, Suk Won Lee, Jeong Yeon Kim, Beom Jong Song, In Gie Hong, Sung Mo Park, Ji Hye Kim, Jun Uk Lee, Bo Bae An
Estimating the term…
The present disclosure relates to a composition for treating anxiety disorder, particularly to a pharmaceutical composition comprising N-acetyl-L-cysteine or its derivatives for treating anxiety disorder such as post traumatic stress disorder or phobia. In accordance with the present disclosure, N-acetyl-L-cysteine can block the renewal of fear memories for a sustained period of time when it was administered during or after an exposure therapy to treat post traumatic stress disorder or phobia.
1-6. (canceled)
A pharmaceutical composition comprising N-acetyl-L-cysteine or a derivative thereof for treating post-traumatic stress disorder, phobia or panic disorder.
A method for treating post-traumatic stress disorder, phobia or panic disorder comprising administering an effective amount of N-acetyl-L-cysteine or a derivative thereof to a subject in need thereof.
Dependencies are inferred from the claim text.